Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo Strikes Imitrex Needle-Free Drug Delivery Deal With Weston

Executive Summary

Glaxo Wellcome will begin clinical trials with sumatriptan delivered via Weston Medical's Intraject needle-free technology in early 2000, with a product launch anticipated for 2003.

You may also be interested in...



Principia Developing Albumin-Fused Human Growth Hormone, Interferon Alfa

Biotech start-up Principia has two albumin-fused protein product candidates in development: human growth hormone and interferon alfa.

European Biotechs Question Sustainability Of Platform Technologies

European biotech companies are facing the question of whether they can sustain themselves over the long-term by focusing on a single platform technology, Ernst & Young suggested in its sixth annual report on the European Life Sciences Industry.

Merck Maxalt-MLT Quick-Dissolve Tab To Be Available In Mid-August

Merck's Maxalt-MLT orally dissolving tablets will become available in mid-August, three weeks after the launch of the conventional tablet form of the drug.

Related Content

UsernamePublicRestriction

Register

PS035047

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel